DK204791D0 - Hidtil ukendt farmaceutisk praeparat - Google Patents

Hidtil ukendt farmaceutisk praeparat

Info

Publication number
DK204791D0
DK204791D0 DK912047A DK204791A DK204791D0 DK 204791 D0 DK204791 D0 DK 204791D0 DK 912047 A DK912047 A DK 912047A DK 204791 A DK204791 A DK 204791A DK 204791 D0 DK204791 D0 DK 204791D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
growth hormone
dissolved
formulation
unknown pharmaceutical
Prior art date
Application number
DK912047A
Other languages
English (en)
Inventor
Hans Holmegaard Soerensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK912047A priority Critical patent/DK204791D0/da
Publication of DK204791D0 publication Critical patent/DK204791D0/da
Priority to US07/827,178 priority patent/US5977069A/en
Priority to CZ941458A priority patent/CZ282826B6/cs
Priority to AT93902088T priority patent/ATE177645T1/de
Priority to DE69228704T priority patent/DE69228704T2/de
Priority to EP93902088A priority patent/EP0618806B1/en
Priority to AU33445/93A priority patent/AU664416B2/en
Priority to KR1019940702140A priority patent/KR100270726B1/ko
Priority to RO94-01055A priority patent/RO112086B1/ro
Priority to HU9401831A priority patent/HUT69682A/hu
Priority to CA002125856A priority patent/CA2125856A1/en
Priority to SK737-94A priority patent/SK73794A3/sk
Priority to RU9494045921A priority patent/RU2098130C1/ru
Priority to PCT/DK1992/000378 priority patent/WO1993012811A1/en
Priority to JP51136093A priority patent/JP3662580B2/ja
Priority to NZ246555A priority patent/NZ246555A/en
Priority to BG98804A priority patent/BG98804A/bg
Priority to NO942299A priority patent/NO942299D0/no
Priority to FI942905A priority patent/FI942905A/fi
Priority to US08/469,283 priority patent/US5851992A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK912047A 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat DK204791D0 (da)

Priority Applications (20)

Application Number Priority Date Filing Date Title
DK912047A DK204791D0 (da) 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat
US07/827,178 US5977069A (en) 1991-12-20 1992-01-28 Pharmaceutical formulation
NZ246555A NZ246555A (en) 1991-12-20 1992-12-16 Pharmaceutical composition containing a growth hormone and asparagine
RO94-01055A RO112086B1 (ro) 1991-12-20 1992-12-16 Preparate farmaceutice continand hormoni de crestere sau derivat al acestora
SK737-94A SK73794A3 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical formulation comprising growth hormone and aspargine
DE69228704T DE69228704T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
EP93902088A EP0618806B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
AU33445/93A AU664416B2 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
KR1019940702140A KR100270726B1 (ko) 1991-12-20 1992-12-16 성장호르몬과 아스파라진으로 이루어지는 안정화된 약학제제
CZ941458A CZ282826B6 (cs) 1991-12-20 1992-12-16 Stabilizovaný farmaceutický přípravek obsahující růstový hormon a asparagin a jeho použití
HU9401831A HUT69682A (en) 1991-12-20 1992-12-16 Process for producing stabilized pharmaceutical formulations comprising growth hormone and asparagine
CA002125856A CA2125856A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
AT93902088T ATE177645T1 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
RU9494045921A RU2098130C1 (ru) 1991-12-20 1992-12-16 Фармацевтический препарат гормона роста и его стабилизатор
PCT/DK1992/000378 WO1993012811A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
JP51136093A JP3662580B2 (ja) 1991-12-20 1992-12-16 成長ホルモンおよびアスパラギンを含んでなる安定化医薬製剤
BG98804A BG98804A (bg) 1991-12-20 1994-05-30 Стабилизирана фармацевтична форма,съдържаща растежен хормон и аспарагин
NO942299A NO942299D0 (no) 1991-12-20 1994-06-17 Stabilisert, farmasöytisk preparat som omfatter veksthormon og asparagin
FI942905A FI942905A (fi) 1991-12-20 1994-06-17 Stabiloitu kasvuhormonia ja asparagiinia sisältävä farmaseuttinen formulointi
US08/469,283 US5851992A (en) 1991-12-20 1995-06-06 Treatment of growth hormone deficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK912047A DK204791D0 (da) 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
DK204791D0 true DK204791D0 (da) 1991-12-20

Family

ID=8109696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK912047A DK204791D0 (da) 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat

Country Status (19)

Country Link
US (2) US5977069A (da)
EP (1) EP0618806B1 (da)
JP (1) JP3662580B2 (da)
KR (1) KR100270726B1 (da)
AT (1) ATE177645T1 (da)
AU (1) AU664416B2 (da)
BG (1) BG98804A (da)
CA (1) CA2125856A1 (da)
CZ (1) CZ282826B6 (da)
DE (1) DE69228704T2 (da)
DK (1) DK204791D0 (da)
FI (1) FI942905A (da)
HU (1) HUT69682A (da)
NO (1) NO942299D0 (da)
NZ (1) NZ246555A (da)
RO (1) RO112086B1 (da)
RU (1) RU2098130C1 (da)
SK (1) SK73794A3 (da)
WO (1) WO1993012811A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
ZA96122B (en) * 1995-01-13 1996-07-24 Novo Nordisk As A pharmaceutical formulation
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
KR19980701351A (ko) * 1995-01-13 1998-05-15 슈타르 피아 성장호르몬 및 Ｘ-Ｌｙｓ를 함유하는 안정화된 약제조제물(A STABILIZED PHARMACEUTICAL FORMULATION COMPRISING A GROWTH HORMONE AND X-Lys
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
ZA965367B (en) * 1995-07-12 1997-01-23 Novo Nordisk As A pharmaceutical formulation
JP4060884B2 (ja) * 1995-08-28 2008-03-12 昭和薬品化工株式会社 局所麻酔用組成物
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
HU228426B1 (hu) 1996-07-24 2013-03-28 Warner Lambert Co Izobutil-gaba és származékai alkalmazása fájdalom kezelésére alkalmas gyógyszer elõállítására
US6696063B1 (en) * 1998-12-30 2004-02-24 Applied Research Systems Ars Holding N.V. Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
MXPA03001092A (es) * 2000-08-07 2003-09-25 Nektar Therapeutics Al Corp Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
WO2002092619A2 (en) 2001-05-14 2002-11-21 The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Modified growth hormone
RU2234945C2 (ru) * 2002-10-15 2004-08-27 Вардосанидзе Ирина Викторовна Стабилизатор водного раствора и водосодержащего сырья с самопроизвольно изменяющимися окислительно-восстановительными свойствами
DE10333317A1 (de) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
US20080213377A1 (en) * 2006-12-08 2008-09-04 Bhatia Sangeeta N Delivery of Nanoparticles and/or Agents to Cells
US20160015789A1 (en) * 2014-07-17 2016-01-21 Teva Pharmaceutical Industries, Ltd. FORMULATIONS OF AN ALBUMIN hGH FUSION PROTEIN

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
EP0303746B2 (en) * 1987-08-21 1998-12-02 Mallinckrodt Group Inc. Stabilization of growth promoting hormones
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5122512A (en) * 1988-09-12 1992-06-16 Pitman-Moore, Inc. Swine growth promoting composition
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
ES2291264T3 (es) * 1991-12-20 2008-03-01 Novo Nordisk A/S Formulacion farmaceutica estabilizada comprendiendo una hormona de crecimiento e histidina.
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
DE69329651T3 (de) * 1992-07-31 2008-10-30 Genentech, Inc., South San Francisco Wässrige arzneizusammensetzung, welche das menschliche wachstumshormon enthält
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation

Also Published As

Publication number Publication date
EP0618806A1 (en) 1994-10-12
CZ282826B6 (cs) 1997-10-15
DE69228704D1 (de) 1999-04-22
CA2125856A1 (en) 1993-07-08
HUT69682A (en) 1995-09-28
RU94045921A (ru) 1996-08-27
US5851992A (en) 1998-12-22
NO942299L (no) 1994-06-17
AU3344593A (en) 1993-07-28
HU9401831D0 (en) 1994-09-28
ATE177645T1 (de) 1999-04-15
JP3662580B2 (ja) 2005-06-22
US5977069A (en) 1999-11-02
NZ246555A (en) 1996-03-26
CZ145894A3 (en) 1994-12-15
EP0618806B1 (en) 1999-03-17
DE69228704T2 (de) 1999-09-16
FI942905A0 (fi) 1994-06-17
RO112086B1 (ro) 1997-05-30
KR940703689A (ko) 1994-12-12
SK73794A3 (en) 1995-03-08
AU664416B2 (en) 1995-11-16
KR100270726B1 (ko) 2000-11-01
WO1993012811A1 (en) 1993-07-08
RU2098130C1 (ru) 1997-12-10
FI942905A (fi) 1994-06-17
BG98804A (bg) 1995-02-28
NO942299D0 (no) 1994-06-17
JPH07502515A (ja) 1995-03-16

Similar Documents

Publication Publication Date Title
DK204791D0 (da) Hidtil ukendt farmaceutisk praeparat
ES2185625T3 (es) Formulacion farmaceutica estabilizada que incluye hormona de crecimiento e histidina.
IL115590A0 (en) Pharmaceutical formulation comprising a growth hormone and isoleucine
PT785795E (pt) Composicao farmaceutica
DK157689A (da) Farmaceutiske piroxicammidler i vandige oploesninger samt fremgangsmaade til fremstilling heraf
IL115592A (en) Stabilized pharmaceutical formulation comprising a growth hormone and leucine
NO884123D0 (no) Stabilisering av terapeutisk virksomme proteiner i farmasoeytiske preparater.
NO980103L (no) Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung

Legal Events

Date Code Title Description
ATS Application withdrawn